Fig. 5
From: Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
Go-enrichment and KEGG pathways analysis
Fig. 5 | BMC Urology
From: Proteome-wide Mendelian randomization and therapeutic targets for bladder cancer
Go-enrichment and KEGG pathways analysis